MAPT and Alzheimer disease: The FDG-based model of AI-imputed tau-PET demonstrated a high degree of correlation to ground-truth tau-PET for patients on the MCI-AD spectrum, distinguished tau-positive versus tau-negative patients, and classified diagnostic groups with performance similar to the AV-1451 tau-PET exams.